Back HIV/AIDS HIV/AIDS Topics HIV Prevention

ASM Microbe 2016: PrEP Use Is Rising Fast in U.S., But Large Racial Disparities Remain

More than 49,000 people in the U.S. have filled prescriptions for Truvada for pre-exposure prophylaxis (PrEP) at retail pharmacies, according to the results of a survey by Gilead Sciences presented this week at the ASM Microbe conference in Boston. Among PrEP users with available data, most were white gay men; black people used PrEP much less often, despite having the highest rates of HIV infection.

alt

Read more:

Tenofovir/Emtricitabine Vaginal Ring Protects Monkeys Against HIV-Like Virus

A vaginal ring that releases tenofovir and emtricitabine -- the antiretroviral drugs in the Truvada PrEP pill -- maintained protective drug levels over 4 months, and all macaque monkeys that received the ring were protected from infection with an engineered HIV-like virus, researchers reported in the June 8 edition of PLoS ONE. A human study of a different type of tenofovir ring showed that it maintained protective drug levels in genital fluid and blood over 14 days.

alt

Read more:

American Gay Men's Use of Condoms Has Been Falling for a Decade

There has been a long-term decline in condom use by American gay men, researchers from the Centers for Disease Control and Prevention (CDC) reported in the May 5 online edition of AIDS. Similar declines have been seen among men whose sexual partners were of the same HIV status and among men who did not know their sexual partners’ status -- showing that the fall in condom use cannot be explained by sero-sorting or other sero-adaptive behaviors. Moreover, condom use began to fall long before pre-exposure prophylaxis (PrEP) became available.

alt

Read more:

Small Risk of HIV Sexual Transmission Persists Through First 6 Months of ART

A risk of HIV transmission to sexual partners persists for 6 months after the initiation of antiretroviral therapy (ART), investigators from a large prospective prevention study confirm in the online edition of the Journal of Acquired Immune Deficiency Syndromes.

alt

Read more:

At Least 6000 People Thought to Be on HIV PrEP in San Francisco

New numbers from the city's largest pre-exposure prophylaxis (PrEP) programs, along with estimates from primary providers and other smaller sources, suggest that more than 6000 people in San Francisco are receiving or have received Truvada for HIV prevention, most of them gay and bisexual men.

alt

Read more: